Tag: Mal Hebblewhite
RMIT’s ingestible gut sensor wins FDA approval for US market
An innovative gas-sensing capsule developed at RMIT University to provide real-time insights into gut health has received regulatory clearance from the U.S. Food and Drug Administration (FDA), paving the way for its commercial launch in the United States.
Breakthrough Victoria invests in Atmo’s gastrointestinal disorder diagnostic technology
Breakthrough Victoria has announced that it is investing in medical technology company Atmo Biosciences and its world-first gas-sensing capsule designed to help diagnose functional gastrointestinal disorders.